ACS report: 2024 projected new cancer cases top 2 million

Botensilimab + balstilimab showed no CRC recurrences in resectable colon cancer, phase II NEST trial shows

The phase II NEST trial evaluating neoadjuvant botensilimab, a multifunctional, Fc-enhanced anti-CTLA-4 antibody, and balstilimab, an anti-PD-1 antibody, showed no colorectal cancer recurrences in patients with resectable colon cancer.

September 11, 2026

Vol.52 No.33

Guest Editorial

I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.”

My high school experience revolved around constantly worrying about my four younger siblings and mom amidst our normal condition—instability.

ACS CAN voter poll finds overwhelming support for affordable cancer care, high concern over tobacco usage

A national poll commissioned by the American Cancer Society Cancer Action Network found that likely 2026 voters from both parties overwhelmingly support people having access to cancer screening and care, as well as support for the federal government continuing to invest in cancer research.

August 14, 2026

Vol.52 No.32

Clinical Roundup

Retesting with at-home FIT tests is linked to earlier diagnoses, retrospective cohort study finds

Repeat testing is tied to earlier diagnoses and shaped by health-system outreach, according to a retrospective cohort study of nearly 500,000 adults.

July 24, 2026

Vol.52 No.29

Guest Editorial

Cancer progress is not reaching everyone. Native Nations must be part of the solution.

In 1971, the National Cancer Act set the United States on a path to confront one of its most formidable public health challenges. More than five decades later, the progress is undeniable. The latest 2026 report from the American Cancer Society shows continued declines in overall cancer mortality and improvements in survival for many major cancer types. Recent advances in early detection, prevention, and treatment are saving lives.

FDA proposes rule to hold foreign tobacco companies to U.S. standards

FDA has issued a proposed rule to require both foreign and domestic tobacco manufacturers to register their facilities and list their products with the agency. This closes a regulatory gap, holding overseas e-cigarette and tobacco makers to the same standards as U.S. companies.

July 10, 2026

Vol.52 No.27

By Claire Marie Porter

ACS report: 2024 projected new cancer cases top 2 million

YOU MAY BE INTERESTED IN

Botensilimab + balstilimab showed no CRC recurrences in resectable colon cancer, phase II NEST trial shows

I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.”

ACS CAN voter poll finds overwhelming support for affordable cancer care, high concern over tobacco usage

Retesting with at-home FIT tests is linked to earlier diagnoses, retrospective cohort study finds

Cancer progress is not reaching everyone. Native Nations must be part of the solution.

FDA proposes rule to hold foreign tobacco companies to U.S. standards

Renew today!

Subscriber content

Never miss an issue!

Login

ACS report: 2024 projected new cancer cases top 2 million

YOU MAY BE INTERESTED IN

Botensilimab + balstilimab showed no CRC recurrences in resectable colon cancer, phase II NEST trial shows

I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncologyMy mother instilled in me: “Never become a product of your circumstances.”

ACS CAN voter poll finds overwhelming support for affordable cancer care, high concern over tobacco usage

Retesting with at-home FIT tests is linked to earlier diagnoses, retrospective cohort study finds

Cancer progress is not reaching everyone. Native Nations must be part of the solution.

FDA proposes rule to hold foreign tobacco companies to U.S. standards

Never miss an issue!

Login

I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.”